Antimicrobial peptides: Properties and applicability

Biological Chemistry

Volumn 382, Issue 4, 2001, Pages 597-619

  Van 'T Hof, Wim ^a   Veerman, Enno C I ^a   Heimerhorst, Eva J ^b   Nieuw Amerongen, Arie V ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b BOSTON UNIVERSITY   (United States)

Author keywords

Antibiotics; Histatins; Mechanisms; Models; Therapeutics

Indexed keywords

ANTIINFECTIVE AGENT; DEMEGEN; IB 367; IB 67; MBI 853NL; MEMBRANE PROTEIN; NISIN; OFLOXACIN; PEPTIDE; PEXIGANAN; PEXIGANAN ACETATE; PLACEBO; POLYPEPTIDE ANTIBIOTIC AGENT; RECOMBINANT BACTERICIDAL PERMEABILITY INCREASING PROTEIN; TRIMERIS; UNCLASSIFIED DRUG;

BACTERIUM; BONE MARROW TRANSPLANTATION; CELLULAR IMMUNITY; CHEMICAL STRUCTURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG APPROVAL; DRUG COST; DRUG EFFICACY; DRUG SAFETY; DRUG SENSITIVITY; FOOD AND DRUG ADMINISTRATION; FUNGUS; GRAM NEGATIVE INFECTION; HOSPITAL INFECTION; HUMAN; HUMORAL IMMUNITY; IMMUNE SYSTEM; IMMUNITY; IMMUNOGENICITY; IMPETIGO; MEMBRANE DAMAGE; MENINGOCOCCEMIA; MICROORGANISM; MUCOSA INFLAMMATION; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PROPHYLAXIS; PROTEIN DEGRADATION; REVIEW; SIDE EFFECT; SKIN ULCER; STAPHYLOCOCCUS AUREUS; STOMACH ULCER; SURVIVAL RATE; VIRUS;

AMINO ACID SEQUENCE; ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIA; CELL MEMBRANE STRUCTURES; FUNGI; HUMANS; MODELS, BIOLOGICAL; MOLECULAR CONFORMATION; VIRUSES;

ANIMALIA; BACTERIA (MICROORGANISMS); FUNGI; NEGIBACTERIA; STAPHYLOCOCCUS AUREUS;

EID: 0342902408     PISSN: 14316730     EISSN: None     Source Type: Journal    
DOI: 10.1515/BC.2001.072     Document Type: Review

References (206)

1. Agawa, Y., Lee, S., Ono, S., Aoyagi, H., Ohno, M., Taniguchi, T., Anzai, K., and Kirino, Y. (1991). Interaction with phospholipid bilayers, ion channel formation, and antimicrobial activity of basic amphipathic α-helical model peptides of various chain lengths. J. Biol. Chem. 266, 20218-20222.
2. Agerberth, B., Boman, A., Andersson, M., Jornvall, H., Mutt, V., and Boman, H.G. (1993). Isolation of three antibacterial peptides from pig intestine: gastric inhibitory polypeptide (7-42), diazepam-binding inhibitor (32-86) and a novel factor, peptide 3910. Eur. J. Biochem. 216, 623-629.
3. Ahmad, I., Perkins, W.R., Lupan, D.M., Selsted, M.E., and Janoff, A.S. (1995). Liposomal entrapment of the neutrophil-derived peptide indolicidin endows it with in vivo antifungal activity. Biochim. Biophys. Acta 1237, 109-114.
4. Alvarez-Bravo J., Kurata, S., and Natori, S. (1994). Novel synthetic antimicrobial peptides effective against methicillin-resistant Staphylococcus aureus. Biochem. J. 302, 535-538.
5. Andersson, M., Gunne, H., Agerberth, B., Boman, A., Bergman, T., Olsson, B., Dagerlind, A., Wigzell, H., Boman, H.G., and Gudmundsson, G.H. (1996). NK-lysin, structure and function of a novel effector molecule of porcine T and NK cells. Vet. Immunol. Immunopathol. 54, 123-126.
6. Andreu, D., and Rivas L. (1998). Animal antimicrobial peptides: an overview. Biopolymers 47, 415-433.
7. Atkinson, J.C., Yeh, C., Oppenheim, F.G., Bermudez, D., Baum, B.J., and Fox, P.C. (1990). Elevation of salivary histidine-rich proteins following HIV-1 infection. J. Acq. Immun. Def. Syndromes. 3, 41-48.
8. Bals, R., Weiner, D.J., Moscioni, A.D., Meegalla, R.L., and Wilson, J.M. (1999). Augmentation of innate host defense by expression of a cathelicidin antimicrobial peptide. Infect. Immun. 67, 6084-6089.
9. Banerjee, A., Pramanik, A., Battacharjya, S., and Balaram, P. (1996). Ω-amino acids in peptide design: incorporation into helices. Biopolymers 39, 769-777.
10. Bäuerle, P.A., and Henkel, T. (1994). Function and activation of NF-κB in the immune system. Anna Rev. Immunol. 12, 141-179.
11. Baum., B.J., Bird, J.L., and Longton, W.L (1976) Studies on histidine-rich polypeptides from human parotid saliva. Arch. Biochem. Biophys. 77, 427-436.
12. Bellamy, W., Wakabayashi, H., Takase, M., Kawase, K., Shimamura, S., and Tomita, M. (1993). Killing of Candida albicans by lactoferricin B, a potent antimicrobial peptide derived from the N-terminal region of bovine lactoferrin. Med. Microbiol. Immunol. 182, 97-105.
13. Bessalle R., Gorea, A., Shalit, I., Metzger, J.W., Dass, C., Desiderio, D.M., and Fridkin, M. (1993). Structure-function studies of amphiphilic antibacterial peptides. J. Med. Chem. 36, 1203-1209.
14. Blondelle S.E., and Houghten, R.A. (1992) Design of model amphipathic peptides having potent antimicrobial activities. Biochemistry 31, 12688-12694.
15. Blondelle, S.E., Takahashi, E., Dinh, K.T., and Houghten, R.A. (1995). The antimicrobial activity of hexapeptides derived from synthetic combinatorial libraries. J. Appl. Bacteriol. 78, 39-46.
16. Blondelle, S.E., Takahashi, E., Weber, P.A., and Houghten, R.A. (1994). Identification of antimicrobial peptides by using combinatorial libraries made up of unnatural amino acids. Antimicrob. Agents Chemother. 38, 2280-2286.
17. Boheim, G. (1974). Statistical analysis of alamethicin channels in black lipid membranes. J. Membr. Biol. 19, 277-303
18. Boman, H.G. (1994). Antibacterial peptides. Key components needed in immunity. Cell 65, 205-207.
19. Boman, H.G. (1994). Chairman's opening remarks. In: Antimicrobial peptides (Ciba Foundation Symposium 186), H.G. Boman, J. Marsh, and J.A. Goode, eds. (Chichester, UK: Wiley), pp. 1-4.
20. Boman, H.G., Agerberth, B., and Boman, A. (1993). Mechanism of action on Escherichia coli of cecropin P1 and PR-39, two antibacterial peptides from pig intestine. Infect. Immun. 61, 2978-2984.
21. Boman, H.G., Faye, I., Gudmundsson, G.H., Lee, J.Y., and Lidholm, D.A. (1991). Cell free immunity in Cecropia. A model system for antibacterial proteins. Eur. J. Biochem. 210, 23-31.
22. Bulet, P., Urge, L., Ohresser, S., Hetru, C., and Otvös, L. (1996). Enlarged scale chemical synthesis and range of activity of drosocin, an O-glycosylated antibacterial peptide of Drosophila. Eur. J. Biochem. 238, 64-69.
23. Cabiaux, V., Agerberth, B., Johansson, J., Homble, F., Goormaghtigh, E., and Ruysschaert, J.M. (1994). Secondary structure and membrane interaction of PR-39, a Pro+Arg-rich antibacterial peptide. Eur J. Biochem. 224, 1019-1027.
24. Cardinale, F., Jonak, C., Ligterink, W., Niehaus, K., Boller, T., and Hirt, H. (2000). Differential Activation of Four Specific MAPK Pathways by Distinct Elicitors. J. Biol. Chem. 275, 36734-36740.
25. Carlsson, A., Engström, P., Palva, E.T., and Bennich, H. (1991). Attacin, an antibacterial protein from Hyalophora cecropia, inhibits synthesis of outer membrane proteins in Escherichia coli by interfering with omp gene transcription. Infect. Immun. 59, 3040-3045.
26. Casteels, P., Ampe, C., Jacobs, F., and Tempst, P. (1993). Functional and chemical characterization of Hymenoptaecin, an antimicrobial polypeptide that is infection-inducible in the honeybee (Apis mellifera). J. Biol. Chem. 268, 7044-7054.
27. Casteels, P., and Tempst, P. (1994). Apidaecin-type peptide antibiotics function through a non-poreforming mechanism involving stereospecificity. Biochem. Biophys. Res. Commun. 199, 339-345.
28. Chapple, D.S., Mason, D.J., Joannou, C.L., Odell, E.W., Gant, V. and Evans, R.W. (1998). Structure-function relationship of antibacterial synthetic peptides homologous to a helical surface region on human lactoferrin against Escherichia coli serotype O111. Infect. Immun. 66, 2434-2440.
29. Charlet, M., Chernysh, S., Philippe, H., Hetru, C., Hoffmann, J.A., and Bulet, P. (1996). Innate immunity. Isolation of several cysteine-rich antimicrobial peptides from the blood of a mollusc, Mytilus edulis. J. Biol. Chem. 271, 21808-21813.
30. Chikanishi, T., Hasumi, K., Harada, T., Kawasaki, N., and Endo, A. (1997). Clonostachin, a novel peptaibol that inhibits platelet aggregation. J. Antibiot. (Tokyo) 50, 105-110.
31. Cole, A.M., Weis, P., and Diamond, G. (1997). Isolation and characterization of pleurocidin, an antimicrobial peptide in the skin secretions of winter flounder. J. Biol. Chem. 272, 12008-12013.
32. Cornut I., Büttner, K., Dasseux, J.-L., and Dufourq, J. (1994). Application to the de novo design of ideally amphipathic Leu, Lys peptides with hemolytic activity higher than that of mellitin. FEBS Lett. 349, 29-33.
33. Couto, M.A., Harwig, S.S., and Lehrer, R.I. (1993). Selective inhibition of microbial serine proteases by eNAP-2, an antimicrobial peptide from equine neutrophils. Infect. Immun. 61, 2991-2994.
34. Daschner, F.D., and Kropec, A. (1995). Glycopeptides in the treatment of staphylococcal infections. Eur. J. Clin. Microbiol. Infect. Dis. 14(Suppl. 1), 12-17.
35. Dathe, M., and Wieprecht, T. (1999). Structural features of helical antimicrobial peptides: their potential to modulate activity on model membranes and biological cells. Biochim. Biophys. Acta 1462, 71-87.
36. De Bolle, M.F., Osborn, R.W., Goderis, I.J., Noe, L., Acland, D., Hart, C.A., Torrekens, S., Van Leuven, F., and Broekaert, W.F. (1996). Antimicrobial peptides from Mirabilis jalapa and Amaranthus caudatus: expression, processing, localization and biological activity in transgenic tobacco. Plant Mol. Biol. 31, 993-1008.
37. Debono, M., Turner, W.W., La Grandeur, L., Burkhardt, F.J., Nissen, J.S., Nichols, K.K., Rodriguez, M.J., Zweifel, M.J., Zeckner, D.J., Gordee, R.S., Tang, J., and Parr, T.R. (1995). Semisynthetic chemical modification of the antifungal lipopeptide Echinocandin B (ECB): structure-activity studies of the lipophilic and geometric parameters of polyarylated acyl analogs of ECB. J. Med. Chem. 38, 3271-3281.
38. De Lucca, A.J., Bland, J.M., Grimm, C., Jacks, T.J., Cary, J.W., Jaynes, J.M., Cleveland, T.E., and Walsh, T.J. (1998a). Fungicidal properties, sterol binding, and proteolytic resistance of the synthetic peptide D4E1. Can. J. Microbiol. 44, 514-520.
39. De Lucca, A.J., Bland, J.M., Jacks, T.J., Grimm, C., and Walsh, T.J. (1998b). Fungicidal and binding propertiesof the natural peptides cecropin Band dermaseptin. Med. Mycol. 36, 291-298.
40. Destoumieux D., Bulet, P., Löw, D., Van Dorsselaer, A., Rodriguez, J., and Bachere, E. (1997). Paneaidins, a new family of antimicrobial peptides isolated from the shrimp Panaeus vannamei(decapoda). J. Biol. Chem. 272, 28398-28406.
41. Diamond, G., Russell, J.R, and Bevins, C.L. (1996). Inducible expression of an antibiotic peptide gene in lipopolysaccharide-challenged tracheal epithelial cells. Proc. Natl. Acad. Sci. USA 93, 5156-5160.
42. Dickinson, D.P., Ridall, A.L., and Levine, M.J. (1997). Human submandibular gland statherin and basic histidine-rich peptide are encoded by highly abundant mRNA's derived from a common ancestral sequence. Biochem. Biophys. Res. Commun. 149, 784-790.
43. Edgerton, M., Co, S.E., and Levine, M.J. (1993). Histatins induce leakage from C. albicans cells and model liposome membranes. J. Dent. Res. 72, 322.
44. Edgerton, M., Koshlukova, S.E., Lo, I.E., Chrzan, B.G., Straubinger, R.M., and Raj, P.A. (1998). Candidacidal activity of salivary histatins. Identification of a histatin 5-binding protein on Candida albicans. J. Biol. Chem. 273, 20438-20447.
45. Eisenberg, D., Schwarz E., Komaromy M., and Wall R. (1984). Analysis of membrane and surface protein sequences with the hydrophobic moment plot. J. Mol. Biol. 179, 125-142.
46. Eisenberg, D., and Wesson, M. (1990). The most highly amphiphilic alpha-helices include two amino acid segments in human immunodeficiency virus glycoprotein 41. Biopolymers 29, 171-177.
47. Epand, R.M., and Vogel, H.J. (1999). Diversity of antimicrobial peptides and their mechanism of action. Biochim. Biophys. Acta 1462, 11-28.
48. Epple, P., Apel, K., and Bohlmann, H. (1998). Overexpression of an endogenous thionin enhances resistance of Arabidopsis against Fusarium oxysporum. Plant Cell 9, 509-520.
49. Esser, A.F. (1994). The membrane attack complex of complement. Assembly, structure, and cytotoxic activity. Toxicology 87, 229-247.
50. Fehlbaum, P., Bulet, P., Chemysh, S., Briand, J.P., Roussel, J.P., Letellier, L., Hetru, C., and Hoffmann, J. A. (1996). Structure-activity analysis of thanatin, a 21 -residue inducible insect defense peptide with sequence homology to frog skin antimicrobial peptides. Proc. Natl. Acad. Sci. USA 93, 1221-1225.
51. Fine, D.P., Gewurz, H., Griffis, M., and Lint, T.F. (1983). Meningococcal meningitis in a woman with inherited deficiency of the ninth component of complement. Clin, Immunol. Immunopathol. 28, 413-417.
52. Frohm, M., Agerberth, B., Ahangari, G., Stahle-Backdahl, M., Lider, S., Wigzell, H., and Gudmundsson, G.H. (1997). The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders. J. Biol. Chem. 272, 15258-15263.
53. Fujita, M., Fujita, T., and Inai, S. (1992). Inherited deficiency of ninth component of complement associated with streptococcal infections. Acta Paediatrica Japonica 34, 169-172.
54. Ganz, T. (1994): Biosynthesis of defensins and other antimicrobial peptides. In: Antimicrobial peptides (Ciba Foundation Symposium 186), H.G. Boman, J. Marsh, and J.A. Goode, eds. (Chichester, UK: Wiley), pp. 62-71.
55. Ganz, T., and Lehrer, R.I. (1995): Defensins. Pharmac. Ther. 66, 191-205.
56. Ganz, T., Metcalf, J.A, Gallin, J.L., Boxer, L.A., and Lehrer, R.I. (1988). Microbicidal/cytotoxic proteins of neutrophils are deficient in two disorders: Chediak-Higashi syndrome and 'specific' granule deficiency. J. Clin. Invest. 82, 552-556.
57. Ghosh, J.K., Shaool, D., Guillaud, P., Ciceron, L., Mazier, D., Kustanovich, I., Shai, Y., and Mor, A. (1997) Selective cytotoxicity of dermaseptin S3 toward intraerythrocytic Plasmodium falciparum and the underlying molecular basis. J. Biol. Chem. 272, 31609-31616.
58. Giacometti, A., Cirioni, O., Barchiesi, F., Fortuna, M., and Scalise G. (1999). In-vitro activity of cationic peptides alone and in combination with clinically used antimicrobial agents against Pseudomonas aeruginosa. J. Antimicrob. Chemother. 44, 641-645.
59. Giroir, B.P., Quint, P.A., Barton, P., Kirsch, E.A., Kitchen, L., Goldstein, B., Nelson, B.J., Wedel, N.J., Carroll, S.F., and Scannon, P.J. (1997). Preliminary evaluation of recombinant amino-terminal fragment of human Bactericidal/Permeability-Inducing protein in children with severe meningococcal sepsis. Lancet 350, 1439-1443.
60. Gomez-Gomez, L., Felix, G., and Boller, T. (1999). A single locus determines sensitivity to bacterial flagellin in Arabidopsis thaliana. Plant J. 18, 277-284.
61. Gouch, M. Hancock, R.E.W., and Kelly, N.M. (1996). Anti-endotoxic potential of cationic peptide antimicrobials. Infect. Immun. 64, 4922-4927.
62. Groenink, J., Walgreen-Weterings, E., Van 't Hof, W., Veerman, E.C.I., and Nieuw Amerongen, A.V. (1999). Cationic amphipathic peptides, derived from bovine and human lactoferrins, with antimicrobial activity against oral pathogens. FEMS Microbiol. Lett. 179, 217-222.
63. + environments. J. Bacteriol. 179, 7040-7045.
64. Gudmundsson, G.H., Agerberth, B., Odeberg, J., Bergman, T., Olsson, B., and Salcedo, R. (1996). The human gene FALL39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes. Eur. J. Biochem. 238, 325-332.
65. Gwadz, R.W., Kaslow, D., Lee, J-Y., Maloy, L., Zasloff, M., and Miller, L.H. (1989). Effects of magainins and cecropins on the sporogenic development of malaria parasites in mosquitoes. Infect. Immun. 57, 2628-2633.
66. Hancock, R.E.W. (1997). Peptide antibiotics. Lancet 349, 418-422.
67. Hancock, R.E.W., and Chapple, D.S. (1999). Peptide antibiotics. Antimicrob. Agents Chemother. 43, 1317-1323.
68. Hancock, R.E.W., and Lehrer, R.I. (1998). Cationic peptides: a new source of antibiotics. Trends Biotechnol. 16, 82-88.
69. Harder, J., Bartels, J., Christophers, E., and Schröder. J-M. (1997). A peptide antibiotic from human skin. Nature 387, 861-862.
70. Harder, J., Meyer-Hoffert, U., Teran, L.M., Schwichtenberg, L., Bartels, J., Maune, S., and Schröder, J-M. (2000). Mucoid Pseudomonas aeruginosa, TNF-α, and IL-1β, but not IL-6, induce human β-defensin-2 in respiratory epithelia. Am. J. Respir. Cell Mol. Biol. 22, 714-721.
71. He, K., Ludtke S.J., Heller W.T., and Huang H.W. (1996). Mechanism of alamethicin insertion into lipid bilayers. Biophys. J. 71, 2669-2679.
72. Helmerhorst, E.J., Van 't Hof, W., Veerman, E.C.I., Simoons-Smit, I., and Nieuw Amerongen, A.V. (1997). Synthetic histatin analogues with broad-spectrum antimicrobial activity. Biochem. J. 326, 39-45.
73. Helmerhorst, E.J., Breeuwer, P., Van 't Hof, W., Walgreen-Weterings, E., Oomen, L.C.J.M., Veerman, E.C.I., Nieuw Amerongen, A.V., and Abee, T. (1999a). The cellular target for histatin 5 on Candida albicans is the energized mitochondrion. J. Biol. Chem. 274, 7286-7291.
74. Helmerhorst, E.J., Reijnders, I.M., Van 't Hof, W., Simoons-Smit, I., Veerman, E.C.I., and Nieuw Amerongen, A.V. (1999b). Amphotericin B and fluconazole-resistant Candida spp., Aspergillus fumigatus, and other newly emerging pathogenic fungi are susceptible to basic antifungal peptides. Antimicrob. Agents Chemother. 43, 702-704.
75. Helmerhorst, E.J., Reijnders, I.M., Van 't Hof, W., Veerman, E.C.I., and Nieuw Amerongen, A.V. (1999c). A critical evaluation of the lytic activity of cationic antimicrobial peptides against Candida albicans cells and human erythrocytes. FEBS Lett. 449, 105-110.
76. Helmerhorst, E.J., Hodgson, R., Van 't Hof, W., Veerman, E.C.I., Allison, C., and Nieuw Amerongen, A.V. (1999d). Effect of histatin-derived basic antimicrobial peptides on oral biofilms. J. Dent. Res. 78, 1245-1250.
77. Hoess, A., Watson, S., Siber, G.R., and Lidington, R. (1993). Crystal structure of an endotoxin-neutralizing protein from the horseshoe crab, Limulus anti-LPS factor, at 1.5 A resolution. EMBO J. 12, 3351-3356.
78. Hong, S.Y., Oh, J.E., Kwon, M., Choi, M.J., Lee, J.H., Lee, B.L., Moon, H.M., and Lee, K.H. (1998). Identification and characterization of novel antimicrobial decapeptides generated by combinatorial chemistry. Antimicrob. Agents Chemother. 42, 2534-2541.
79. Hong, S.Y., Oh, J.E., and Lee, K.H. (1999). In vitro antifungal activity and cytotoxicity of a novel membrane-active peptide. Antimicrob. Agents Chemother. 43, 1704-1707.
80. Horiuchi, T., Nishizaka, H., Kojima, T., Sawabe, T., Niho, Y., Schneider, P.M., Inaba, S., Sakai, K., Hayashi, K., Hashimura, C., and Fukumori, Y. (1998). A non-sense mutation at Arg95 is predominant in complement 9 deficiency in Japanese. J. Immunol. 160, 1509-1513.
81. Houghten, R.A. (1993). The broad utility of soluble peptide libraries for drug discovery. Gene 137, 7-11.
82. Houghten, R.A., Appel, J.R., Blondelle, S.E., Cuervo, J.H., Dooley, C.T., and Pinilla, C. (1992). The use of synthetic peptide combinatorial libraries for the identification of bioactive peptides. BioTechniques 13, 412-421.
83. Houghten, R.A., Pinilla, C., Blondelle, S.E., Appel, J.R., Dooley, C.T., and Cuervo, J.H. (1991). Generation and use of synthetic peptide combinatorial libraries for basic research and drug discovery. Nature 354, 84-86.
84. Imanishi, S., Kito-Nakamura, K., Matsuoka, K., Morikami, A., and Nakamura, K. (1997). A major jasmonate-inducible protein of sweet potato, ipomoelin, is an ABA-independent wound-inducible protein. Plant Cell Physiol. 38, 643-652.
85. lontcheva, I., Oppenheim, F.G., and Troxler, R.F. (1997). Human salivary mucin MG1 selectively forms heterotypic complexes with amylase, proline-rich proteins, statherin, and histatins. J. Dent. Res. 76, 734-743.
86. Jach, G., Gornhardt, B., Mundy, J., Logemann, J., Pinsdorf, E., Leah, R., Schell, J., and Maas, C. (1995). Enhanced quantitative resistance against fungal disease by combinatorial expression of different barley antifungal proteins in transgenic tobacco. Plant J. 8, 97-109.
87. Jainkittivong, A., Johnson, D.A., and Yeh, C-K. (1998). The relationship between salivary histatins and oral yeast carriage. Oral Microbiol. Immunol. 13, 1811-187.
88. Javadpour, M.M., Juban, M.M., Lo, W.-C., Bishop, S.M., Alberty, J.B., Cowell, S.M., Becker, C.L., and McLaughlin, M.L. (1996). De novo antimicrobial peptides with low mammalian cell toxicity. J. Med. Chem. 39, 3107-3113.
89. Jaynes, J.M., Burton, C.A., Barr, S.B., Jeffers, G.W, Julian, G.R., White, K.L., Enright, F.M., Kiel, R., and Laine, R.A. (1988). In vitro cytocidal effect of novel lytic peptides on Plasmodium falciparum and Trypanosoma cruzi. FASEB J. 2, 2878-2883.
90. Jones, E.M., Smart, A., Bloomberg, G., Burgess, L., and Millar, M.R. (1994). Lactoferricin, a new antimicrobial peptide. J. Appl. Bacteriol. 77, 208-214.
91. Jung, G. (1991). Lantibiotics: ribosomally synthesized biologically active polypeptides containing sulfide bridges and α,β-didehydroamino acids. Angew. Chem. Int. Ed. Engl. 30, 1051-1068.
92. Juretic. D., Hendler, R.W., Kamp, F., Caughey, W.S., Zasloff, M., and Westerhoff, H.V. (1994). Magainin oligomers reversibly dissipate delta microH+ in cytochrome oxidase liposomes. Biochemistry 33, 4562-4570.
93. Juvvadi, P., Vunnam, S., Merrifield, E.L., Boman, H.G., and Merrifield, R.B. (1996). Hydrophobic effects on antibacterial and channel-forming properties of cecropin A-melittin hybrids. J. Peptide Sci. 2, 223-232.
94. Kang, J.H., Lee, M.K., Kim, K.L. and Hahm, K.S. (1996). Structure-biologic activity relationships of 11-residue highly basic peptide segment of bovine lactoferrin. Int. J. Peptide Protein Res. 48, 357-363.
95. Keller, H., Pamboukdjian, N., Ponchet, M., Poupet, A., Delon, R., Verrier, J.L., Roby, D., and Ricci, P. (1999). Pathogen-induced elicitin production in transgenic tobacco generates a hypersensitive response and nonspecific disease resistance. Plant Cell 11, 223-235.
96. Kleinkauf, H., and Von Dohren, H. (1990). Nonribosomal biosynthesis of peptide antibiotics. Eur. J. Biochem. 192, 1-15.
97. Kim, H.S., Park, C.B., Kim, M.S., and Kim, S.C. (1996). cDNA cloning and characterization of buforin I, an antimicrobial peptide: a cleavage product of histone H2A. Biochem. Biophys. Res. Commun. 229, 381-387.
98. Koshlukova, S.E., Lloyd, T.L., Araujo, M.W., and Edgerton, M. (1999). Salivary histatin 5 induces non-lytic release of ATP from Candida albicans leading to cell death. J. Biol. Chem. 274, 18872-18879.
99. Krensky, A.M. (2000). Granulysin: a novel antimicrobial peptide of cytolytic T lymphocytes and natural killer cells. Biochem. Pharmacol. 59, 317-320
100. Krisanaprakornkit, S., Kimball, J.R., Weinberg, A., Darveau, R.P, Bainbridge, B.W., and Dale, B.A. (1998a). Inducible expression of human β-defensin 2 by Fusobacterium nucleatum in oral epithelial cells: multiple signaling pathways and role of commensal bacteria in innate immunity and the epithelial barrier. Infect. Immun. 68, 2907-2915.
101. Krisanaprakornkit, S., Weinberg, A., Perez, C.N., and Dale, B.A. (1998b). Expression of the peptide antibiotic human β-defensin 1 in cultured gingival epithelial cells and gingival tissue. Infect. Immun. 66, 4222-4228.
102. Lal, K., Pollock, J.J., Santarpia III, R.P., Heller, H.M., Kaufman, H.W., Fuhrer, J., and Steigbigel, R.T. (1992). Pilot study comparing the salivary cationic protein concentration in healthy adults and AIDS patients: correlation with antifungal activity. J. Acq. Immun. Def. Syndromes 5, 904-914.
103. Larrick, J.W., Morgan, J.G., Palings, I., Hirata, M., and Yen, M.H. (1991). Complementary DNA sequence of rabbit CAP18-a unique lipopolysaccharide binding protein. Biochem. Biophys. Res. Commun. 179, 170-175.
104. Larrick, J.W., Hirata, M., Balint, R.F., Lee, J., Zhong, J., and Wright, S.C. (1995). Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein. Infect, Immun. 63, 1291-1297.
105. Lee, I.H., Cho, Y., and Lehrer, R.I. (1997). Styelins, broad-spectrum antimicrobial peptides from the solitary tunicate, Styela clava. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 118, 515-521.
106. Lehrer, R.I., and Ganz, T. (1996). Endogenous vertebrate antibiotics. Defensins, protegrins, and other cysteine-rich antimicrobial peptides. Ann. NY Acad. Sci. 797, 228-239.
107. Leippe, M. (1995). Ancient weapons: NK-lysin, is a mammalian homolog to pore-forming peptides of a protozoan parasite. Cell 83, 17-18.
108. Lemaitre, B., Reichhart, J.M., and Hoffmann, J.A. (1997). Drosophila host defense: differential induction of antimicrobial peptide genes after infection by various classes of microorganisms. Proc. Natl. Acad. Sci. USA 94, 14614-14619.
109. Leubner-Metzger, G., Petruzzelli. L., Waldvogel, R., Vogeli-Lange, R., and Meins, F. Jr. (1998). Ethylene-responsive element binding protein (EREBP) expression and the transcriptional regulation of class I β-1,3-glucanase during tobacco seed germination. Plant Mol. Biol. 38, 785-795.
110. Levashina, E.A., Ohresser, S., Bulet, P., Reichhart, J.M., Hetru, C., and Hoffmann, J.A. (1995). Metchnikowin, a novel immune-inducible proline-rich peptide from Drosophila with antibacterial and antifungal properties. Eur. J. Biochem. 233, 694-700.
111. Lichtenstein, A.K., Ganz, T., Nguyen, T.M., Selsted, M.E., and Lehrer, R.I. (1988). Mechanism of target cytolysis by peptide defensins. Target cell metabolic activities, possibly involving endocytosis, are crucial for expression of cytotoxicity. J. Immunol. 140, 2686-2694.
112. Liskamp, R.M.J. (1994). Opportunities for new chemical libraries: unnatural biopolymers and diversomers. Angew. Chem. Int. Ed. Engl. 33, 633-636.
113. 123). J. Biol. Chem. 269, 1865-1872.
114. Liu, L., Wang, L., Jia, H.P., Zhao, C., Heng, H.H.Q., Schutte, B.C., McCray, P.B. Jr., and Ganz, T. (1998). Structure and mapping of the human β-defensin HBD-2 gene and its expression at sites of inflammation. Gene 222, 237-244.
115. Locardi, E., Mammi, S., Peggion, E., Monaco, V., Formaggio, F., Crisma, M., Toniolo, C., Bodo, B., Rebuffat, S., Kamphuis, J., and Broxterman, Q.B. (1998) Conformation and membrane activity of an analogue of the peptaibol antibiotic trichogin GA IV with a lipophilic amino acid at the N-terminus. J. Peptide Sci. 4, 389-399.
116. Ludtke, S.J., He, K., Heller, W.T., Harroun, T.A., Yang, L. and Luang, H.W. (1996). Membrane pores induced by magainin. Biochemistry 35, 13723-13728.
117. Mackay, B.J., Denepitiya, L., lacono, V.J., Krost, S.B., and Pollock, J.J. (1984). Growth-inhibitory and bactericidal effects of human parotid salivary histidine-rich polypeptides on Streptococcus mutans. Infect. Immun. 44, 695-701.
118. Mandel, I.D., Barr, C.E., and Turgeon L. (1992). Longitudinal study of parotid saliva in HIV-1 infection. J. Oral Pathol. Med. 21, 209-213.
119. Matsuzaki, K. (1999). Why and how are peptide-lipid interactions utilized for self-defense? Magainins and tachyplesins as archetypes. Biochim. Biophys. Acta 1462, 1-10.
120. Meister, M., Lemaitre, B., and Hoffmann, J.A. (1997). Antimicrobial peptide defense in Drosophila. BioEssays 19, 1019-1026.
121. Miyasaki, K.T., and Lehrer, R.I. (1998). β-Sheet antibiotic peptides as potential dental therapeutics. Int. J. Antimicrob. Agents 9, 269-280.
122. Murphy, S., and Pinney, R.J. (1995). Teicoplanin or vancomycin in the treatment of Gram-positive infections. J. Clin. Pharm. Ther. 20, 5-11.
123. Nicolas, E., Reichhart, J.M., Hoffmann, J.A., and, Lemaitre, B. (1998). In vivo regulation of the I-κB homologue cactus during the immune response of Drosophila. J. Biol. Chem. 273, 10463-10469.
124. Nicolay, K., Laterveer, F.D., and Van Heerde, W.L. (1994). Effects of amphipathic peptides, including presequences, on the functional integrity of rat liver mitochondrial membranes. J. Bioenerg. Biomembr. 26, 327-334.
125. Nürnberger, T., Nennstiel, D., Jabs, T., Sacks, W.R., Hahlbrock, K., and Scheel, D., (1994). High affinity binding of a fungal oligopeptide elicitor to parsley plasma membranes triggers multiple defense responses. Cell 78, 449-460.
126. Nykanen, A., Vesanen, S., and Kallio, H. (1998). Synergistic antimicrobial effect of nisin whey permeate and lactic acid on microbes isolated from fish. Lett. Appl. Microbiol. 27, 345-348.
127. O'Connell, B.C., Xu, T., Walsh, T.J., Sein, T., Mastrangeli, A., Crystal, R.G., Oppenheim, F.G., and Baum, B.J. (1996). Transfer of a gene encoding the anticandidal protein histatin 3 to salivary glands. Hum. Gene Ther. 7, 2255-2261.
128. Oh, J., Cajal, Y., Skowronska, E.M., Belkin, S., Chen, J., Van Dyk, T.K., Sasse,r M., and Jain, M.K. (2000). Cationic peptide antimicrobials induce selective transcription of micF and osmY in Escherichia coli. Biochim. Biophys. Acta 1463, 43-54.
129. Oppenheim, F.G. (1989). Salivary histidine-rich proteins. In: Human Saliva: Clinical Chemistry and Microbiology 1, J.O., Tenovuo, ed. (Boca Raton, USA: CRC Press), pp. 151-160.
130. Oppenheim, F.G., Xu, T., McMillian, F.M., Levitz, S.M., Diamond, R.D., Offner, G.D., and Troxler, R.F. (1988). Histatins, a novel family of histidine-rich proteins in human parotid secretion. Isolation, characterization, primary structure, and fungicidal effects on Candida albicans. J. Biol. Chem. 263, 7472-7477.
131. Ostresh, J.M., Blondelle, S.E., Dörner, B., and Houghten, R.A. (1996). Generation and use of nonsupported-bound peptide and peptidomimetic combinatorial libraries. Methods Enzymol. 267, 220-234.
132. Palfreyman, J.W., Aitcheson, T.C., and Taylor, P. (1984). Guidelines for the production of polypeptide specific antisera using small synthetic oligopeptides as imrnunogens. J. Immunol. Methods 75, 383-393.
133. Park, C.B, Kim, H.S., and Kim, S.C. (1998a). Mechanism of action of the antimicrobial peptide buforin II: buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions. Biochem. Biophys. Res. Commun. 244, 253-257.
134. Park, I.Y., Park, C.B., Kim, M.S., and Kim, S.C. (1998b). Parasin I, an antimicrobial peptide derived from histone H2A in the catfish, Parasilurus asotus. FEBS Lett. 437, 258-262.
135. Paquette, D.W., Waters, G.S., Stefanidou, V.L., Lawrence, H.P., Friden, P.M., O'Connor, S.M., Sperati, J.D., Oppenheim, F.G., Hutchens, L.H., and Williams, R.C. (1997). Inhibition of experimental gingivitis in beagle dogs with topical salivary histatins. J. Clin. Periodontol. 24, 216-222.
136. Penninckx, I.A.M.A., Thomma, B.P.H.J., Buchala, A., Métraux, J.-P., and Broekaert, W.F. (1998). Concomitant activation of jasmonate and ethylene response pathways is required for induction of a plant defensin gene in Arabidopsis. Plant Cell 10, 2103-2113.
137. Perinpanayagam, H.E.R., Van Wuyckhuyse, B.C., Ji, Z.S., and Tabak, L.A. (1995). Characterization of low-molecular-weight peptides in human parotid saliva. J. Dent. Res. 74, 345-350.
138. Piers, K.L., and Hancock, R.E. (1994). The interaction of a recombinant cecropin/melittin hybrid peptide with the outer membrane of Pseudomonas aeruginosa. Mol. Microbiol. 12, 951-958.
139. Piers, K.L., Brown, M.H., and Hancock, R.E.W. (1994). Improvement of outer membrane-permeabilization and lipopolysaccharide-binding activities of an antimirobial cationic peptide by C-terminal modification. Antimicrob. Agents Chemother. 38, 2311-2316.
140. Pieterse, C.M., and Van Loon, L.C. (1999). Salicylic acid-independent plant defence pathways. Trends Plant Sci. 4, 52-58.
141. Pinilla, C., Appel, J.R., Blondelle, S.E., Dooley, C.T., Dörner, B., Eichler, J., Ostresh, J.M., and Houghten, R.A. (1995). A review of the utility of soluble peptide combinatorial libraries. Biopolymers 37, 221-240.
142. Pollock, J.J., Denepitiya, L., Mackay, B.J., and lacono, V.J. (1984). Fungistatic and fungicidal activity of human parotic salivary histidine-rich polypeptides on Candida Albicans. Infect. Immun. 44, 702-707.
143. Pollock, JJ., Santarpia III, R.P., Heller, H.M., Xu, L., Lal, K., Fuhrer, J., Kaufman, H.W., and Steigbigel, R.T. (1992). Determination of salivary anticandidal activities in healthy adults and patients with AIDS: a pilot study. J. Acq. Immun. Def. Syndromes 5, 610-618.
144. Popken-Harris, P., Thomas, L., Oxvig, C., Sottrup-Jensen, L., Kubo, H., Klein, J.S., and Gleich, G.J. (1994). Biochemical properties, activities, and presence in biological fluids of eosinophil granular major basic protein. J. Allergy Clin, Immunol. 94, 1282-1289.
145. Powell, W.A., Catranis, C.M., and Maynard, C.A. (1995). Synthetic antimicrobial peptide design. Mol. Plant Microbe Interact. 8, 792-794.
146. Raj, P.A., Edgerton, M., and Levine M.J. (1990). Salivary histatin 5: dependence of sequence, chain length and helical conformation for candidacidal activity. J. Biol. Chem. 265, 3898-3905.
147. Robinson, W., McDougall, B., Tran, D. and Selsted, M.E. (1998). Anti-HIV activity of indolicidin, an antimicrobial peptide from neutrophils. J. Leukoc. Biol. 63, 94-100.
148. Ruissen. A.L.A., Van der Reijden, W.A., Van 't Hof, W., Veerman, E.C.I., Nieuw Amerongen, A.V. (1999). Anti-fungal activity of a cationic peptide, analogous to salivary histatin 5, mixed with and covalently linked to xanthan. J. Controlled Rel. 60, 49-56.
149. Russell, J.P., Diamond, G., Tarver, A.P., Scanlin, T.F., and Bevins, C.L. (1996). Coordinate induction of two antibiotic genes in tracheal epithelial cells exposed to the inflammatory mediators lipopolysaccharide and tumor necrosis factor alpha. Infect. Immun. 64, 1565-1568.
150. Sabatini, L.M., Ota, T., and Azen, E.A. (1993). Nucleotide sequence analysis of the human salivary protein genes HIS1 and HIS2 and evolution of the STATH/HIS gene family. Mol. Biol. Evol. 10, 497-511.
151. Samakovlis, C., Kylsten, P., Kimbrell, D.A., Engstrom, A., and Hultmark, D. (1991). The andropin gene and its product, a male-specific antibacterial peptide in Drosophila melanogaster. EMBO J. 10, 163-169.
152. Sanchez-Monge, R., Blanco, C., Perales, A.D., Collada, C., Carrillo. T., Aragoncillo, C., and Salcedo, G. (2000). Class I chitinases, the panallergens responsible for the latex-fruit syndrome, are induced by ethylene treatment and inactivated by heating. J. Allergy Clin. Immunol. 106, 190-195.
153. Santarpia III, R.P., Pollock, J.J., Renner, R.P., and Gwinnett, A.J. (1991). In vivo antifungal efficacy of salivary histidine-rich polypeptides: preliminary findings in a denture stomatitis model system. J. Prosthet. Dent. 66, 693-699.
154. Saryan, J.A., Dammin, T.C., and Bouras, A.E. (1998). Anaphylaxis to topical bacitracin zinc ointment. Am. J. Emerg. Med. 16, 512-513.
155. Schibli, D.J., Hwang, P.M., and Vogel, H.J. (1999). The structure of the antimicrobial active center of lactoferricin B bound to sodium dodecyl sulfate micelles. FEBS Lett. 446, 213-217.
156. Schofield, C.J., Baldwin, J.E., Byford, M.F., Clifton, I., Hajdu, J., Hensgens, C., and Roach, P. (1997). Proteins of the penicillin biosynthesis pathway. Curr. Opin. Struct. Biol. 7, 857-864.
157. Schumann, R.R., Leong, S.R., Flaggs, G.W., Gray, RW., Wright, S.D., Mathison, J.C., Tobias, P.S., and Ulevitch, R.J. (1990). Structure and function of lipopolysaccharide binding protein. Science 249, 1429-1431.
158. Scott, J.K. (1992). Discovering peptide ligands using epitope libraries. Trends Biochem. Sci. 17, 241-245.
159. Scott, M.G., Gold, M.R., and Hancock, R.E. (1999a). Interaction of cationic peptides with lipoteichoic acid and Gram-positive bacteria. Infect. Immun. 67, 6445-6453.
160. Scott, M.G., Yan, H., and Hancock, R.E. (1999b). Biological properties of structurally related alpha-helical cationic antimicrobial peptides. Infect. Immun. 67, 2005-2009.
161. Shai, Y. (1999). Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by α-helical antimicrobial and cell non-selective membrane-lytic peptides. Biochim. Biophys. Acta 1462, 55-70.
162. Shimazu, R., Akashi, S., Ogata, H., Nagai, Y., Fukudome, K., Miyake, K., and Kimoto, M. (1999). MD2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J. Exp. Med. 189, 1777-1782.
163. Shresta, P., Hashimoto, J., Takagi, H., Yamada, K., Mori, M., Kanehira, T., Wang, P., and Kuboki, Y. (1994). Immunoreactive histatin 5 in salivary gland tumors. Acta Histochem. Cytochem. 27, 527-534.
164. Simmaco, M., Mignogna, G., Barra, D., and Bossa, F. (1994). Antimicrobial peptides from skin secretions of Rana esculenta. Molecular cloning of cDNAs encoding esculentin and brevinins and isolation of new active peptides. J. Biol. Chem. 269, 11956-11961.
165. Sitaram, N., and Nagaraj, R. (1995). Seminalplasmin. BioEssays 17, 415-422.
166. Situa, H., Balasubramanian, S.V., and Bobek, L.A. (2000). Role of α-helical conformation of histatin-5 in candidacidal activity examined by proline variants. Biochim. Biophys. Acta 1475, 377-382.
167. Sjoholm, A.G. (1990). Inherited complement deficiency states: implications for immunity and immunologic disease. APMIS 98, 861-874.
168. Skerlavaj, B., Gennaro, R., Bagella, L., Merluzzi, L., Risso, A., and Zanetti, M. (1996). Biological characterization of two novel cathelicidin-derived peptides and identification of structural requirements for their antimicrobial and cell-lytic actvities. J. Biol. Chem. 271, 28375-28381.
169. Soballe, P.W., Maloy, W.L., Myrga, M.L., Jacob, L.S., and Herlyn, M. (1995). Experimental local therapy of human melanoma with lytic magainin peptides. Int. J. Cancer 60, 280-284.
170. Sørensen, O., Bratt, T., Johnsen, A.H., Thorup Madsen. M., and Borregaard, N. (1999) The human antibacterial cathelicidin, hCAP-18, is bound to lipoproteins in plasma. J. Biol. Chem. 274, 22445-22451.
171. Subramaniam, R., Despres, C., and Brisson. N. (1997). A functional homolog of mammalian protein kinase C participates in the elicitor-induced defense response in potato. Plant Cell 9, 653-664.
172. Sugiyama, K., Ogino, T., and Ogata, K. (1990). Rapid purification and characterization of histatins (histidine-rich polypeptides) from human whole saliva. Arch. Oral Biol. 35, 415-419.
173. Suzuki, S., Ohe, Y., Okubo, T., Kakegawa, T., and Tatemoto, K. (1995). Isolation and characterization of novel antimicrobial peptides, rugosins A, B and C, from the skin of the frog, Rana rugosa. Biochem. Biophys. Res. Commun. 212, 249-254.
174. Tailor, R.H., Acland, D.P., Attenborough, S., Cammue, B.P., Evans, I.J., Osborn, R.W., Ray, J.A., Rees, S.B., and Broekaert, W.F. (1997). A novel family of small cysteine-rich antimicrobial peptides from seeds of Impatiens balsamina is derived from a single precursor protein. J. Biol. Chem. 272, 24480-24487.
175. Takeuchi, O., Hoshino, K., Kawai, T., Sanjo, H., Takada, H., Ogawa, T., Takeda, K., and Akira, S. (1999). Differential roles of TLR2 and TLR4 in recognition of Gram-negative and Gram-positive cell wall components. Immunity 11, 443-451.
176. 7]-polyphemusin-II), with gp120 and CD4 by surface plasmon resonance. Biochim. Biophys. Acta 1298, 37-44.
177. Tang, Y-Q., Yuan, J., Ösapay, G., Ösapay, K., Tran, D., Miller, C.J., Ouelette, A.J., and Selsted, M.E. (1999). A cyclic antimicrobial peptide produced in primate leukocytes by the ligation of two truncated α-defensins. Science 286, 498-502.
178. Tencza, S.B., Douglass, J.P., Creighton Jr, D.J., Montelaro, R.C., and Mietzner, T.A. (1997). Novel antimicrobial peptides derived from human immunodeficiency virus type 1 and other lentivirus transmembrane proteins. Antimicrob. Agents Chemother. 41, 2394-2398.
179. Thomma, B.P.H.J, Eggermont, K., Penninckx, I.A.M.A., MauchMani, B., Vogelsang, R., Cammue, B.P.A., and Broekaert, W.F. (1998). Separate jasmonate-dependent and salicylate-dependent defense response pathways in Arabidopsis are essential for resistance to distinct microbial pathogens. Proc. Natl. Acad. Sci. USA 95, 15107-15111.
180. Thomma, B.P., Eggermont, K., Tierens, K.F., and Broekaert, W.F. (1999). Requirement of functional ethylene-insensitive 2 gene for efficient resistance of Arabidopsis to infection by Botrytis cinerea. Plant Physiol. 121, 1093-1102.
181. Tomita, M., Takase, M., Bellamy, W., and Shimamura, S. (1994). A review: the active peptide of lactoferrin. Acta Ped. Japonica 36, 585-591.
182. Troxler, R.F., Offner, G.D., Xu, T., Vanderspek, and J.C., Oppenheim F.G. (1990). Structural relationships between human salivary histatins. J. Dent. Res. 69, 2-6.
183. Tsai, H., and Bobek, L.A. (1998). Human salivary histatins: promising anti-fungal therapeutic agents. Crit. Rev. Oral Biol. Med. 9, 480-497.
184. Tsai, H., Raj, P.A., and Bobek, L.A. (1996). Candidacidal activity of recombinant human salivary histatin 5 and variants. Infect. Immun. 64, 5000-5007.
185. Urban, B.W., Hlady S.B., and Haydon D.A. (1980). Ion movements in gramicidin pores. An example of single-file transport. Biochim. Biophys. Acta 602, 331-354.
186. Utsugi, T., Schroit, A.J., Connor, J., Bucana, C.D., and Fidler, I.J. (1991). Elevated expression of phosphatidylserine in the outer membrane leaflet of human tumor cells and recognition by activated human blood monocytes. Cancer. Res. 51, 3062-3066.
187. Vaara, M., and Porro, M. (1996). Group of peptides that act synergistically with hydrophobic antibiotics against Gram-negative enteric bacteria. Antimicrob. Agents Chemother. 40, 1801-1805.
188. Van Abel, R.J., Tang, Q.-Y., Rao, V.S.V., Dobbs, C.H., Tran, D., Barany, G., and Selsted, M.E. (1995). Synthesis and characterization of indolicidin, a tryptophan-rich antimicrobial peptide from bovine neutrophils. Int. J. Peptide Protein Res. 445, 401-409.
189. Van den Berg, R.H., Faber-Krol, M.C., Van Wetering, S., Hiemstra, P.S., and Daha, M.R. (1998). Inhibition of activation of the classical pathway of complement by human neutrophil defensins. Blood 92, 3898-3903.
190. Van 't Hof, W., Reijnders, I.M., Helmerhorst, E.J., Walgreen-Weterings, E., Simoons-Smit, I.M., Veerman, E.C., and Nieuw Amerongen, A.V. (2000). Synergistic effects of low doses of histatin 5 and its analogues on amphotericin B anti-mycotic activity. Antonie Van Leeuwenhoek 78, 163-169.
191. Van Wetering, S., Mannesse-Lazeroms, S.P.G., Van Sterkenburg, M.A., Daha, M.R., Dijkman, J.H., and Hiemstra, P.S. (1997). Effect of defensins on interleukin-8 synthesis in airway epithelial cells. Am. J. Physiol. 272, L888-896.
192. Wachinger, M., Kleinschmidt, A., Winder, D., Von Pechmann, N., Ludvigsen, A., Neumann, M., Holle, R., Salmons, B., Erfle, V., and Brack-Werner, R. (1998). Antimicrobial peptides melittin and cecropin inhibit replication of human immunodeficiency virus 1 by suppressing viral gene expression. J. Gen. Virol. 79, 731-740.
193. Wakabayashi, H., Abe, S., Okutomi, T., Tansho, S., Kawase, K., and Yamaguchi, H. (1996). Cooperative anti-Candida effects of lactoferrin or its peptides in combination with azole antifungal agents. Microbiol. Immunol. 40, 821-825
194. Wakabayashi, H., Okutomi, T., Abe, S., Hayasawa, H., Tomita, M., and Yamaguchi, H. (1998). Enhanced anti-Candida activity of neutrophils and azole antifungal agents in the presence of lactoferrin-related compounds. Adv. Exp. Med. Biol. 443, 229-237.
195. Welling, M.M., Hiemstra, P.S., Van den Barselaar, M.T., Paulusma-Annema, A., Nibbering, P.H., Pauwels, E.K., and Calame, W. (1998). Antibacterial activity of human neutrophil defensins in experimental infections in mice is accompanied by increased leukocyte accumulation. J. Clin. Invest. 102, 1583-1590.
196. Wösten, M.M., and Groisman, E.A. (1999). Molecular characterization of the PmrA regulon. J. Biol. Chem. 274, 27185-27190.
197. Wu, M., Maier E., Benz, R., and Hancock, R.E.W. (1999). Mechanism of interaction of different classes of cationic antimicrobial peptides with planar bilayers and with the cytoplasmic membrane of Escherichia coli. Biochemistry 38, 7235-7242.
198. Xu, L., Lal, K., Santarpia III, R.P., and Pollock J.J. (1993). Salivary proteolysis of histidine-rich polypeptides and the anti-fungal activity of peptide degradation products. Arch. Oral Biol. 38, 277-283.
199. Xu, T., Telser, E., Troxler, R.F., and Oppenheim F.G. (1990). Primary structure and anticandidal activity of the major histatin from parotid secretion of the subhuman primate Macaca fascicularis. J. Dent. Res. 69, 1717-1723.
200. Xu, Y., Ambudkar, I., Yamagishi, H., Swaim, W., Walsh, T.J., and O'Connell, B.C. (1999). Histatin 3-mediated killing of Candida albicans: effect of extracellular salt concentration on binding and internalization. Antimicrob. Agents Chemother. 43, 2256-2262.
201. Yaniv, M., Dabbi, D., Amir, H., Cohen, S., Mozes, M., Tsuberi, H., Frietkin, M., Dekel, S., and Ofek, I. (1999). Prolonged leaching time of peptide antibiotics from acrylic bone cement. Clin. Orthop. 363, 232-239.
202. Yeaman, M.R., Norman, D.C., and Bayer, A.S. (1992). Platelet microbicidal protein enhances antibiotic-induced killing of and postantibiotic effect in Staphylococcus aureus. Antimicrob. Agents Chemother. 36, 1665-1670.
203. Yu. Y.G., King, D.S., and Shin, Y.-K. (1994). Insertion of a coiled-coil peptide from influenza virus hemagglutinin into membranes. Science 266, 274-276.
204. Zanetti, M., Del Sal, G., Storici, P., Schneider, C., and Romeo, D. (1993). The cDNA of the neutrophil antibiotic Bac5 predicts a pro-sequence homologous to a cysteine proteinase inhibitor that is common to other neutrophil antibiotics. J. Biol. Chem. 268, 522-526.
205. Zasloff, M. (1994) Discussion in: Antimicrobial peptides (Ciba Foundation Symposium 186), H.G. Boman, J. Marsh, and J.A. Goode, eds (Chichester, UK: Wiley), pp. 151-159.
206. Zoppi, M., Weiss, M., Nydegger, U.E., Hess, T., and Spath, P.J. (1990). Recurrent meningitis in a patient with congenital deficiency of the C9 component of complement. First case of C9 deficiency in Europe. Arch. Int. Med. 150, 2395-2399.